# Sun Pharmaceutical Industries shares jumped over 6% in early trade and were trading at around ₹1,725 on both BSE and NSE at the time of writing.

*business · news · 2026-04-27 · NewsX*

## Key points

- Sun Pharma will acquire US-based Organon & Co. in an all-cash deal worth $11.75 billion.
- The deal will make Sun Pharma and Organon a combined entity operating in over 150 countries.
- Post-acquisition, at least 18 markets will generate over $100 million in annual revenue each.
- The deal boosts Sun Pharma's position in women’s health and biosimilars globally.

**Companies:** Sun Pharmaceutical Industries, Merck & Co.
**Countries:** India, United States

[Read the full story on NewsX](https://www.newsx.com/business/sun-pharmas-organon-acquisition-sun-pharma-to-acquire-us-based-drugmaker-organon-for-1175-billion-205763/)

---

Canonical: https://newsio.io/n/49daaa13-1e72-4d85-b22e-862156da95e0/sun-pharmaceutical-industries-shares-jumped-over-6-in-early-trade-and-were-tradi
Summarized by Newsio from NewsX. https://newsio.io/how-it-works